Fibrocystic mastopathy (FCM) is a common benign disease of the mammary gland, which is characterized by the presence of fibrous changes and cystic formations in its tissues. This condition is often accompanied by pain, swelling and changes in the structure of the mammary gland. FCM arose as a mechanism of adaptation and formation of a response of the mammary glands to various hormonal, metabolic and exogenous factors. The disease is mainly observed in women of reproductive age, but can also occur in older patients. The main clinical complaint is pain in the mammary gland, which can intensify before menstruation. In most cases, the disease is under control and does not require serious intervention, but it can cause significant concern in women, which requires a qualified medical approach.
History of the disease and interesting historical facts
Fibrocystic mastopathy has been known to doctors since ancient times, when medical treatises described various conditions of the mammary glands. In the 19th century, they began to systematically study the structures of the breast and their pathologies. Thus, in 1842, the French doctor Bodin first described changes associated with fibrosis in the tissues of the mammary gland. The study of FCM became intensive in the 20th century, when with the development of technology, higher-quality methods of radiological and morphological research became available. It is interesting that the term "mastopathy" appeared in medicine as an attempt to combine various changes in the mammary gland, including both benign and malignant processes. In the 1970s, large studies were conducted to determine the relationship between FCM and breast cancer, which largely changed the view on the diagnosis and treatment of this disease.
Epidemiology
Fibrocystic mastopathy is considered one of the most common breast pathologies. According to statistics, FCM occurs in 30-50% of women aged 20 to 50 years. According to the World Health Organization, the greatest number of cases are registered during the reproductive period. Studies show that among women of privileged socioeconomic status, the incidence of FCM is about 40%, while among less affluent groups this figure reaches 20-30%. It is important to note that the incidence of FCM varies depending on the geographic region, race and ethnicity. For example, in Europe and North America, the incidence is higher than in Asia and Africa.
Genetic predisposition to this disease
Genetic predisposition to fibrocystic breast disease continues to be an important area of research. Some studies suggest that mutations in certain genes may increase the risk of developing the disease. Of particular interest is the influence of genes such as BRCA1 and BRCA2, known to be associated with breast cancer. In addition, associations have been observed between FCM and alternative polymorphisms of other genes responsible for hormone metabolism and metabolism. First of all, such genetic markers may indicate features of estrogen and progesterone metabolism, which in turn may contribute to the development of fibrous and cystic changes in breast tissue. Thus, genetic studies are becoming an important component in understanding the pathogenesis of FCM and finding an individualized approach to treatment.
Risk factors for the development of this disease
Mastopathy can develop under the influence of many factors, both physical and chemical:
- Hormonal changes: Fluctuations in estrogen and progesterone levels most often lead to changes in the structure of breast tissue.
- Heredity: Having a family history of FCM or breast cancer may increase your risk of developing the disease.
- Age: FCM is most common in women of reproductive age, especially in the period under 40 years.
- Stress: psycho-emotional stress can become a trigger for an exacerbation of the manifestations of the disease.
- Environmental factors: Exposure to chemicals and pollution can negatively impact breast health.
- Poor diet: Low fiber intake and high fat content in the diet can negatively affect the condition of the breasts.
Diagnosis of this disease
Diagnosis of fibrocystic mastopathy is based on clinical and laboratory approaches:
- Main symptoms: the most characteristic manifestations are pain and enlargement of the mammary glands, as well as the presence of lumps upon palpation.
- Lab tests: Blood tests can help assess hormone levels and rule out other conditions.
- Radiological examinations: Mammography is becoming the main imaging method, along with breast ultrasound, which is particularly useful in diagnosing cysts.
- Other types of diagnostics: if necessary, biopsies are performed to exclude malignant tumors.
- Differential diagnosis: It is important to differentiate FCM from other breast diseases such as fibroadenoma and cancer.
Treatment
Treatment of fibrocystic mastopathy is mainly conservative, but may also include surgical intervention.
- General treatment: includes lifestyle changes, diet and stress reduction.
- Pharmacological treatment: use of non-steroidal anti-inflammatory drugs, hormonal therapy, vitamins and minerals.
- Surgical treatment: In rare cases where the condition worsens significantly or cysts need to be removed, surgery may be required.
- Other treatments: Physical therapy and natural remedies may be used to relieve symptoms.
List of medications used to treat this disease
Various medications are used in the treatment of fibrocystic mastopathy:
- Ibuprofen: for pain relief
- Paracetamol: to reduce pain and fever
- Preparations with female sex hormone: for correction of hormonal background
- Calcium and magnesium: to strengthen breast tissue
- Vitamins E and B: to improve metabolism in mammary gland cells
Disease monitoring
Monitoring the condition of a patient with fibrocystic mastopathy includes regular examinations and diagnostics for control stages:
- Control stages: you should visit your doctor at least once every six months to assess changes, as well as if new symptoms appear.
- Prognosis: Most cases of FCM are benign and will stabilize with proper management.
- Complications: Rare complications may include the development of mastitis or a cyst with infection.
Age-related features of the disease
Fibrocystic mastopathy has its own characteristics depending on age:
- Young women: more likely to suffer from severe pain and the presence of cysts.
- Middle-aged women: may experience less severe symptoms, but the likelihood of chronicity is higher.
- Older women: FCM often becomes less severe, but complications may arise due to the influence of other chronic diseases.
Questions and Answers
- What are the main symptoms of fibrocystic breast disease? The main symptoms are pain in the mammary glands, changes in the shape and size of the breasts, and the presence of lumps.
- Can fibrocystic breast disease be prevented? It is impossible to completely prevent the disease, but maintaining a healthy lifestyle and regular medical examinations can significantly reduce the risks.
- How often do you need to get checked? It is recommended to undergo examination at least once every six months.
- Will fibrocystic mastopathy develop into cancer? In most cases, FCM is benign and the risk of transformation into cancer is low, but requires careful monitoring.
- What are the main treatment methods for fibrocystic breast disease? Treatment may include hormone therapy, pain medications, and lifestyle changes.
Dr. Oleg Korzhikov emphasizes that fibrocystic mastopathy requires careful attention. Key tips include regular self-examinations, a healthy lifestyle, and seeing a doctor when the first signs appear. He strongly recommends not to panic if you have concerns about your breast condition, and to follow your doctor’s recommendations to minimize the risk of exacerbations. It is important to remember that the disease is manageable, and its symptoms can be effectively controlled with the right approach.
